A phase II trial of AZD1152 in relapsed/refractory diffuse large B‐cell lymphoma. (26th February 2015) - Collins, Graham P.; Eyre, Toby A.; Linton, Kim M.; Radford, John; Vallance, Grant D.; Soilleux, Elizabeth; Hatton, Chris